Pruritus skin disease
Conditions
Interventions
CU Control group:Loratadine tablets
CU Treatment group:Loratadine tablets and electrical stimulation of auricular point
AD Control group:Loratadine tablets 10mg/ time, once a day, for 4 weeks
AD Treatment group:Loratadine tablets and electrical stimulation of auricular point
Sponsors
Hebei University of Chinese Medicine/ Hebei Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria for chronic urticaria (CU) or atopic dermatitis (AD); (2) 18 years old = age =70 years old; (3) Not participating in other ongoing clinical investigators; (4) Normal liver and kidney function; (5) Voluntary signing of informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with unconsciousness, unable to express subjective discomfort symptoms and patients with anxiety, depression and psychosis; (2) Patients with severe primary diseases such as tumor, cardiovascular, endocrine, hematopoietic and other diseases; (3) The skin around the auricle is infected; (4) Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urticaria activity score;Scoring Atopic Dermatitis Index(SCORAD); | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual analogue score of itch;Dermatology Life Quality Index; | — |
Countries
China
Contacts
Public ContactYanjun Wang
Hebei Provincial Hospital of Chinese Medicine
Outcome results
None listed